IP Library Granted Patent US 9,254,270
Granted Patent B2
US 9,254,270 · App. 13/693,332 · Granted Feb 9, 2016

Enteric soft capsules

Inventors: EmadEldin M. Hassan (Parkton, MD); Aqeel A. Fatmi (High Point, NC); Nachiapan Chidambaram (Sandy, UT)
Assignee: Banner Life Sciences LLC
A61K9/4866A61K9/4816A61K9/4858
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,254,270
App. No.
13/693,332
Granted
Feb 9, 2016
Kind
B2
Abstract

A gel mass is provided that is useful in manufacturing enteric soft or hard capsules, or enteric tablets without coating.

Claims (35)

1. An enteric soft capsule shell formed from a gel mass comprising:

(a) a gelatin,

(b) an acid-insoluble polymer;

(c) an alkaline aqueous solvent; and

(d) a plasticizer;

wherein the gelatin and acid-insoluble polymer together comprise 45% by weight of the gel mass;

the ratio of acid-insoluble polymer to gelatin is from 30:70 to 45:55 by weight;

the final pH of the gel mass is less than or equal to about 9 pH units; and

the final moisture content of the enteric soft capsule shell formed from the gel mass composition is from about 2% to about 10%.

2. The enteric soft capsule shell of claim 1 , wherein the gelatin comprises at least about 25% by weight of the gel mass.

3. The enteric soft capsule shell of claim 1 , wherein gelatin comprises about 25% to about 36% by weight of the gel mass.

4. The enteric soft capsule shell of claim 1 , wherein the acid-insoluble polymer comprises at most about 20% by weight of the gel mass.

5. The enteric soft capsule shell of claim 1 , wherein the acid-insoluble polymer comprises about 8% to about 20% by weight of the gel mass.

6. The enteric soft capsule shell of claim 1 , wherein the gelatin is extracted from animal bones or skins, and has a bloom value of about 100 to about 250.

7. The enteric soft capsule shell of claim 1 , wherein the acid-insoluble polymer is selected from the group consisting of acrylic and methacrylic acid copolymers and cellulose acetate esters.

8. The enteric soft capsule shell of claim 7 , wherein the acid-insoluble polymer is methacrylic acid copolymers.

9. The enteric soft capsule shell of claim 1 , wherein the plasticizer is selected from the group consisting of sorbitol, glycerol, polyethylene glycol, poly-alcohols with 3 to 6 carbon atoms, citric acid, citric acid esters, triethyl citrate, and combinations thereof.

10. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent comprises an alkali selected from the group consisting of ammonia, sodium hydroxide, potassium hydroxide, ethylenediamine, hydroxylamine, and tri-ethanolamine.

11. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent comprises a volatile alkali.

12. The enteric soft capsule shell of claim 11 , wherein the volatile alkali is selected from the group consisting of ammonia and ethylenediamine.

13. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent is a hydroalcoholic solution.

14. The enteric soft capsule shell of claim 1 , where the final pH of the gel mass is less than or equal to about 8.5.

15. The enteric soft capsule shell of claim 1 , wherein the gel mass has a moisture content of from about 9% to about 35%.

16. The enteric soft capsule shell of claim 1 , wherein the final moisture content of the enteric soft capsule shell formed from the gel mass composition is from about 4% to about 8%.

17. The enteric soft capsule shell of claim 1 , wherein the ratio of plasticizer to gelatin is from about 1:9 to about 1:1 by weight.

18. The enteric soft capsule shell of claim 1 , wherein the ratio of plasticizer to gelatin is about 1:2 by weight.

19. The enteric soft capsule shell of claim 1 , wherein the plasticizer comprises about 17% of the gel mass.

20. The enteric soft capsule shell of claim 1 , wherein the thickness of the capsule shell is from about 0.015 inches to about 0.050 inches.

21. A process of manufacturing enteric soft capsules, the process comprising

(a) preparing a gel mass of claim 1 ;

(b) casting the gel mass into films using heat-controlled drums or surfaces; and

(c) forming a soft capsule using rotary die technology.

22. The enteric soft capsule shell of claim 1 , wherein the plasticizer is glycerol.

23. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent is ammonia.

24. The enteric soft capsule shell of claim 7 , wherein the cellulose acetate ester is selected from the group consisting of phthalate, butyrate, hydropropyl methylcellulose phthalate and salts thereof.

Assignments (8)
RELEASE (REEL 032403 / FRAME 0790) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BANNER PHARMACAPS INC.
Reel/Frame 044038/0028 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032403/0790) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043173/0005 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC; BANNER PHARMACAPS INC.
Reel/Frame 036224/0623 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC
Reel/Frame 036239/0188 →
SECURITY INTEREST Recorded Mar 5, 2015
From: BANNER LIFE SCIENCES LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 035133/0328 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 19, 2014
From: BANNER PHARMACAPS INC
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034294/0916 →
SECURITY INTEREST Recorded Mar 11, 2014
From: BANNER PHARMACAPS INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032403/0790 →
Continuity (4)
Continuation 10529984
Provisional Application 60415187 · Oct 1, 2002
Related Publication 20140154311A1 · Jun 5, 2014
Related Publication 20150352054A9 · Dec 10, 2015